FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
EO-1606, 344457-87-0, EO-1606 Intermediate 7073-36-1, stock 796.7g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
EO-1606, 344457-87-0, EO-1606 Intermediate 95-46-5, stock 716.4g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
EO-1606, 344457-87-0, EO-1606 Intermediate 344459-21-8, stock 237.5g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
EO-1606, 344457-87-0, EO-1606 Intermediate 210967-34-3, stock 732.7g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
EO-1606, 344457-87-0, EO-1606 Intermediate 452-63-1, stock 922.3g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
EO-1606, 344457-87-0, EO-1606 Intermediate 344457-87-0, stock 829.4g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |